Overexpression of miR -155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Zhao, Xu dong ^a   Zhang, Wei ^a   Liang, Hong jun ^a   Ji, Wen yue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 155; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFECTION;

EID: 84874279917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056395     Document Type: Article

References (28)

1. Genden EM, Ferlito A, Silver CE, Jacobson AS, Werner JA, et al. (2007) Evolution of the management of laryngeal cancer Oral Oncology. 43: 431-439.
2. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Ling H, Zhang W, Calin GA, (2011) Principles of microRNA involvement in human cancers. Chinese journal of cancer 30: 739-748.
4. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
5. Lagos QM, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
6. Xie Q, Chen X, Lu F, Zhang T, Hao M, et al. (2011) Aberrant Expression of MicroRNA 155 May Accelerate Cell Proliferation by Targeting Sex-Determining Region Y Box 6 in Hepatocellular Carcinoma. Cancer [Epub ahead of print].
7. Liu J, Gao J, Du Y, Li Z, Ren Y, et al. (2011) Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. International journal of cancer [Epub ahead of print].
8. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, et al. (2011) The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clinical cancer research 17: 1875-1882.
9. Wang F, Zheng Z, Guo J, Ding X, (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecologic oncology 119: 586-593.
10. Bakirtzi K, Hatziapostolou M, Karagiannides I, Polytarchou C, Jaeger S, et al. (2011) Neurotensin Signaling Activates MicroRNAs-21 and-155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors. Gastroenterology 141: 1749-1761.
11. Du Z, Hu L, Wang H, Yan L, Zeng Y, et al. (2011) Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A. PLoS One 6: e19137.
12. Jiang S, Zhang H, Lu M, He X, Li Y, et al. (2010) MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene. Cancer Res 70: 3119-3127.
13. Liu B, Ren Z, Shi Y, Guan C, Pan Z, et al. (2008) Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas. Laryngoscope 118: 1976-1980.
14. Starska K, Forma E, Lewy I, Stasikowska O, Bryś M, et al. (2009) The expression of SOCS1 and TLR4-NF B pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. Folia Histochem Cytobiol 47: 401-410.
15. Eis PS, Tam W, Sun L, (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America 102: 3627-3632.
16. Starr R, Willson T, Viney E, Murray L, Rayner J, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921.
17. Chu PY, Yeh CM, Hsu NC, Chang YS, Chang JG, et al. (2010) Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma. Swiss medical weekly 140: w13065.
18. Dunlop EA, Maxwell AP, Lappin TR, (2007) Impaired downregulation following erythropoietin receptor activation in non-small cell lung carcinoma. Stem cells (Dayton, Ohio) 25: 380-384.
19. Komazaki T, Nagai H, Emi M, (2004) Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers. Japanese journal of clinical oncology 34: 191-194.
20. Evans MK, Yu CR, Lohani A, (2007) Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene 26: 1941-1948.
21. Aaronson DS, Horvath CM, (2002) A road map for those who don't know JAK-STAT. Science 296: 1653-1655.
22. Kim BH, Min YS, Choi JS, Baeg GH, Kim YS, et al. (2011) Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signaling. Experimental & molecular medicine 43: 313-321.
23. Kluge A, Dabir S, Vlassenbroeck I, Eisenberg R, Dowlati A, (2011) Protein inhibitor of activated STAT3 expression in lung cancer. Molecular oncology 5: 256-264.
24. Liu Y, Liu A, Li H, Li C, Lin J, (2011) Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells. Cancer prevention research (Philadelphia, Pa.) 4: 1296-1305.
25. Xiong H, Du W, Zhang YJ, Hong J, Su WY, et al. (2011) Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Molecular carcinogenesis [Epub ahead of print].
26. Huang FJ, Steeg PS, Price JE, Chiu WT, Chou PC, et al. (2008) Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer research 68: 9634-9642.
27. Park Y, Shon SK, Kim A, Kim KI, Yang Y, et al. (2007) SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochemical and biophysical research communications 363: 361-367.
28. Flowers LO, Subramaniam PS, Johnson HM, (2005) A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. Oncogene 24: 2114-2120.